Special Issue "Bioactive Secondary Metabolites of Marine Fungi 2.0"
Deadline for manuscript submissions: 20 January 2024 | Viewed by 1689
Interests: marine natural products; biomedical applications; drug discovery; anticancer compounds; anti-inflammatory compounds; antimicrobial compounds
Special Issues, Collections and Topics in MDPI journals
Special Issue in Marine Drugs: Natural Products from Marine Fungi
Special Issue in Marine Drugs: Marine-Derived Compounds Applied in Infectious Diseases
Special Issue in Marine Drugs: Marine Actinomycetes Products
Special Issue in Marine Drugs: Marine Drug Research in Korea
Special Issue in Marine Drugs: Bioactive Secondary Metabolites of Marine Fungi
Special Issue in Marine Drugs: Glycosylated Metabolites from Marine Bacteria
Fungi represent a significant proportion of the microbial diversity on Earth. The discovery of new secondary metabolites from marine fungi has increased dramatically over the last few decades, cumulating in over 1000 new metabolites. The biosynthesis of these metabolites is dependent on ecological, physical and biological factors and, therefore, small changes in these conditions can generate an entirely new set of metabolites. Thus, understanding the chemical language of marine fungi and the development of new culture techniques are needed to discover novel fungal metabolites with potent biological activities.
Based on the success of the Special Issue “Bioactive Secondary Metabolites of Marine Fungi” (https://www.mdpi.com/journal/marinedrugs/special_issues/MarineFungi2022), as well as the critical relevance of this topic, we are pleased to announce the second edition of this Special Issue.
This Special Issue will highlight the marine fungal natural products as potential molecules for the discovery of new drugs, empathizing the structural diversity and bioactivities of marine fungal secondary metabolites.
As a Guest Editor for this Special Issue, I invite you to submit your research results on marine fungi, ranging from the isolation and structure elucidation of new natural products to biosynthetic pathways of marine fungal metabolites.
Prof. Dr. Hee Jae Shin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine fungi
- secondary metabolites
- structure determination
- bioactive compounds
- fungal diversity
- natural products
- therapeutic agents
- novel compounds